Our purpose was to better understand the mutual influence of cis-diamminedichloroplatinum and intercalating drugs in their interactions with DNA. The present study deals with the intercalating drug Nmethyl-2,7-diazapyrenium (MDAP). Two sets of experiments have been performed. In one set, the reaction between cis-DDP and nucleic acid was carried out in the presence of MDAP. The main adduct is a guanine residue chelated by platinum to a MDAP residue. It has the same spectroscopic properties as the synthesized compound cis-[Pt (NH3)2 (N7-dguanosine) (N7-MDAP)] +++, the structure of which has been determined by 'H NMR. This adduct was only formed with double-stranded nucleic acids which reveals the importance of DNA matrix in orienting favorably the reactants. In the second set of experiments, the triamine complex cis-[Pt(NH3)2 (MDAP)CI] ++ was reacted with the nucleic acids. At molar ratios drug over nucleotide residue equal or less than 0.10, all the added triamine complexes bind by covalent coordination to double-stranded nucleic acids.
INTRODUCTION
The antitumor drug cis-DDP is assumed to exhibit its toxicity by reacting with cellular DNA (1) . In the in vivo and in vitro reactions, the two major adducts arise from intrastrand crosslinks between two adjacent guanine residues and between an adenine residue and an adjacent guanine residue, respectively.
Minor adducts arise from intrastrand cross-links between two guanine residues separated by at least one base and from interstrand cross-links between two guanine residues (2) (3) (4) . Drugs known to bind to DNA such as doxorubicin (5, 6) or bleomycin (7) (8) (9) are commonly used therapeutically in combination with cis-DDP. In vitro experiments have demonstrated that the bleomycin cleavage specificity is altered in platinated DNA (10, 11) . The presence of the intercalating drug ethidium bromide during the reaction of platination modulates the cis-DDP binding to DNA (12) (13) (14) (15) (16) . One reason for this modulation is the formation of a new kind of adduct in which ethidium and nucleotide residues are cross-linked by cis-platinum (15) (16) (17) (18) . In the same experimental conditions but in the absence of DNA, cis-DDP is hardly reactive with ethidium bromide (15, 17) . The formation of this new adduct reveals that the DNA double helix acts as a matrix achieving a favorable orientation of the reactants. However, this new adduct is relatively unstable and its nature has been determined by indirect methods (15) (16) (17) (18) .
To go further into our understanding of the mutual influence of cis-DDP and intercalating drugs, we have undertaken a study with the planar cationic compound N-methyl-2,7-diazapyrenium (MDAP). This compound possesses an endocyclic nitrogen atom which was expected to form a stable bond with platinum. Two sets of experiments have been performed. In the first set, DNA was reacted with cis-DDP in the presence of MDAP. We demonstrate that the cross-links occur between base residues and MDAP residues but no longer between two base residues. In the second set of experiments, DNA was reacted with the platinumtriamine complex cis-[Pt(NH3)2(MDAP)Cl] + +. We find that in both the reactions, the same adduct is formed. (20) . The reactive cis-platinum monochloro intermediates were prepared from the reaction of cis-DDP (10 mM) with one equivalent of AgNO3 in dimethyl-formamide during 24 hours at room temperature, followed by centrifugation to remove AgCl. In a second step, two equivalents of cis-platinum monochloro intermediates were reacted with MDAP (10 mM) in dimethylformamide during 90 mn at 60°C. The product was precipitated by addition of S volumes of diethylether at 4°C. The yellow precipitate was dissolved in 0.3 M NaCl and the platinum-triamine complex was purified by HPLC on a 250 x 10 mm C8 column (C8 lichrosorb) attached to (22) and then with alkaline phosphatase (23) . The digests were analyzed by HPLC on a 250 x4.6 mm C18 column (lichrospher CH 18) with a 35 mn linear gradient of 2-15 % buffer B (buffer A, 2% CH3CN, NH4OAc 0.1 M pH 5.9; buffer B, 40% CH3CN, NH4OAc 0. IM pH 5.9; flow rate, 1 ml/mn; detection wavelenght, 260 nm).
The absorption spectra were recorded on a Kontron Uvikon 810 spectrophotometer. IH NMR spectra were recorded on a Bruker AM 300 WB spectrometer operating at 300 MHz. Samples were dissolved in D20 after two lyophilizations in this solvent.pD variations (pH+0.4) were made by use of solution of DNO3 and NaOD.The solvent, used as internal shift reference, was centered at 4 ppm.
RESULTS

1) Reaction between DNA, MDAP and cis-DDP
The interactions between DNA and MDAP have not yet been studied into details. Nevertheless, in 10 mM NaClO4 and after addition of an excess of DNA the changes in the absorption spectrum resembled those of well-characterized intercalating drugs (24, 25) or of the related compound N, N'-dimetyl-2,7-diazapyrenium (26 -28) and were also similar to those of the triamine complex (see fig.3 ) .Thus, we assume that in 10 mM NaClO4 and at molar ratios MDAP per nucleotide equal or less than 0.25, MDAP behaves as an intercalating drug.
The complex between DNA and MDAP was reversible. All the intercalated drug could be removed from DNA by dialysis or by ethanol precipitation. When the reaction between DNA and cis-DDP was performed in the presence of MDAP, some MDAP residues could not be removed by dialysis or by precipitation.As shown in fig. 1 , the molar ratio rb (irreversibly bound MDAP per nucleotide) increases as a function of time and then remains constant. At the plateau, after removal of the unbound drug, the amounts of bound MDAP and bound cis-platinum are approximatively equal. Similar results were obtained with the synthetic polynucleotides poly (dG-dC).poly(dG-dC) and poly(dA-dC).poly(dG-dT). The single-stranded DNA or when cis-DDP is replaced by the isomer trans-DDP ( fig. 1 ). In the same experimental conditions but in the absence of DNA, MDAP reacts weakly with cis-DDP (less than 10%) The nature of the adducts formed in the reaction between DNA, MDAP and cis-DDP has been determined. The reaction mixture (same proportions as in fig. 1 ) was incubated overnight at 37°C and then after addition of NaClO4, the DNA was precipitated with ethanol. The modified DNA was enzymatically digested (22, 23) a) Reaction with dGuo. In water, the triamine complex reacted with dGuo. The main product of the reaction, after HPLC purification, has been studied by IH NMR. Its spectrum ( fig.2 ) corresponds to cis-[Pt(NH3)2(N7-dGuo)(N7-MDAP)](OAc)3. With respect to dGuo, the sugar protons are slightly downfield shifted. The H(8) proton is downfield shifted (0.4 ppm) which is a consequence of the platination at the N(7) (29) (30) (31) (32) (33) . With respect to MDAP, the protons are also slightly downfield shifted. It is likely that the shifts (0.4 ppm) for the H(8) and H(6) protons are also a consequence of the platination at the N(7) position. Some more experiments have been performed as a function of pH. No changes were observed at low pH which confirms that the N(7) of dGuo residues and the N(7) of the MDAP residues are no longer accessible. As the pH was increased above neutral pH, a chemical shift of the H(8) proton of dGuo residues was observed which reflects the titration of the N(1) of the dGuo residues. The pK value (8.2) is lower than that of the unplatinated dGuo residues in agreement with other results (29) . After incubation of this product in 0.2 M NaCN, the HPLC profile presented two peaks corresponding respectively to dGuo and MDAP in equal proportions ( The molar ratio rb has been calculated assuming that the amplitude of the hyperchromic effect (340nm) was independent of the DNA sequence. The accuracy of the method was checked by taking samples at regular time intervals, subsequent removal of the unbound drug by dialysis and by measuring the amount of drug bound to DNA both by visible absorption (MDAP residues) and atomic absorption spectroscopy (platinum residues). A good agreement was found.
From the variation of rb versus time, the half-lives of the reaction were determined. The results relative to the reaction between C.T. DNA and the triamine complex (chloro or aqua species) are shown in the insert of fig.3 . The half-lives are equal to 51 i 3 mn for poly(dG-dC). poly(dG-dC) and C.T. DNA and 320 mn for poly(dA-dT). poly(dA-dT). When the triamine shorter (15 4 In agreement with model studies (17) and with the reactivity of the monofunctional cis-platinum adducts (18) , it is suggested that cis-DDP reacts first with DNA and then the monofunctional adduct reacts with the intercalating drug.
As compared to the complexes DNA-cisPt-ethidium or proflavine (15, 18) unwinding angle at low rb suggest that at least some MDAP nain adduct arises residues are intercalated. Id a dGuo residue.
In conclusion, two reactions lead to the same monofunctional platinum adduct cross-linking the intercalating drug MDAP. Recently, it has been reported that some platinum-triamine complexes of the form cis-[Pt(NH3)2(Am)Cl]+ where Am is a s in the presence heterocyclic amine based on pyridine, pyrimidine, purine, -18) respectively piperidine, have an antitumor activity in vivo (34) . Work is in the DNA double progress to determine whether Am being an intercalating residue, the reactants. The the antitumor activity of the triamine complexes is improved. le-stranded DNA ilar experimental
